MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Pfizer
Pfizer
BSE: 500680|NSE: PFIZER|ISIN: INE182A01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 25, 17:00
1169.05
5.7 (0.49%)
VOLUME 1,011
LIVE
NSE
May 25, 17:00
1164.65
0.35 (0.03%)
VOLUME 3,285
Management Interviews on Pfizer
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Govt needs to relook at draft pharma pricing policy: Pfizer 

1.15 pm | 02 Nov 2011 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Kewal Handa, managing director of Pfizer said, the draft NPPP has a few positives but the government needs to re-look at it alt...

CCI's role key in pharma FDI; FIPB not best option: Pfizer 

9.00 pm | 11 Oct 2011 |  Source: CNBC-TV18

The Arun Maira committee report on pharma FDI was accepted by the government which said the CCI should be entrusted with the task of scrutinising phar...

Strides, Pfizer to deal post US FDA nod on Oncology unit 

12.58 pm | 02 May 2011 |  Source: CNBC-TV18

Strides Arcolab received a nod by the US FDA for an Oncology unit in Bengaluru. Arun Kumar, group CEO and vice chairman of Strides Arcolab, in an excl...

Blocking Ranbaxy's launch of cholesterol drug, where is the logic? 

1.05 pm | 21 Mar 2011 |  Source: CNBC-TV18

The US Foods and Drugs Administration (USFDA) will be sued by the US pharmaceutical company Mylan Inc, for an injunction on the launch of Ranbaxy’s ch...

Business to grow Rs 1000cr in FY11: Stride Arcolab  

6.41 pm | 24 Feb 2011 |  Source: CNBC-TV18

Stride Arcolab announced it Q3 results for FY11. The company reported a consolidated net profit of Rs 122.4 crore for the year ended 2010 as against R...

Have multiple launches planned in 2011, says Pfizer 

1.40 pm | 12 Jan 2011 |  Source: CNBC-TV18

Speaking to CNBC-TV18, Kewal Handa, MD of Pfizer said the firm has planned multiple launches in 2011. "We expect to grow above market rates," he added...

Clinigene & Syngene may list in a year's time: Biocon 

10.59 am | 03 Jan 2011 |  Source: CNBC-TV18

In an exclusive interview with CNBC-TV 18, Kiran Mazumdar Shaw, CMD of Biocon says that Clingene & Syngene to undergo transformation in the business ...

1
Quick Links for Pfizer
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.